Category: Biotechnology Company Reports
Biotechnology Company Reports market research reports by Plunkett Research, Ltd.
-
XOMA Corporation (XOMA:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
XOMA Corporation (XOMA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for XOMA Corporation (XOMA:NAS) compared to its top competitors and compared to the aver ... Read More
-
Puma Biotechnology Inc (PBYI:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Puma Biotechnology Inc (PBYI:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Puma Biotechnology Inc (PBYI:NAS) compared to its top competitors and compared ... Read More
-
International Stem Cell Corp (ISCO:PINX): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
International Stem Cell Corp (ISCO:PINX): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for International Stem Cell Corp (ISCO:PINX) compared to its top competitor ... Read More
-
Protagonist Therapeutics (PTGX:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Protagonist Therapeutics (PTGX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Protagonist Therapeutics (PTGX:NAS) compared to its top competitors and comp ... Read More
-
Heron Therapeutics Inc (HRTX:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Heron Therapeutics Inc (HRTX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Heron Therapeutics Inc (HRTX:NAS) compared to its top competitors and compared ... Read More
-
Biogen Inc (BIIB:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Biogen Inc (BIIB:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Biogen Inc (BIIB:NAS) compared to its top competitors and compared to the average for all ... Read More
-
Gilead Sciences Inc (GILD:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Gilead Sciences Inc (GILD:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Gilead Sciences Inc (GILD:NAS) compared to its top competitors and compared to th ... Read More
-
VBI Vaccines Inc (VBIV:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
VBI Vaccines Inc (VBIV:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for VBI Vaccines Inc (VBIV:NAS) compared to its top competitors and compared to the aver ... Read More
-
Geron Corporation (GERN:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Geron Corporation (GERN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Geron Corporation (GERN:NAS) compared to its top competitors and compared to the av ... Read More
-
Acorda Therapeutics Inc (ACOR:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Acorda Therapeutics Inc (ACOR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Acorda Therapeutics Inc (ACOR:NAS) compared to its top competitors and compar ... Read More
-
United Therapeutics Corporation (UTHR:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
United Therapeutics Corporation (UTHR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for United Therapeutics Corporation (UTHR:NAS) compared to its top compet ... Read More
-
Repligen Corporation (RGEN:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Repligen Corporation (RGEN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Repligen Corporation (RGEN:NAS) compared to its top competitors and compared to ... Read More
-
Moderna Inc (MRNA:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Moderna Inc (MRNA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Moderna Inc (MRNA:NAS) compared to its top competitors and compared to the average for al ... Read More
-
International Stem Cell Corp (ISCO:PINX): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
International Stem Cell Corp (ISCO:PINX): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry International Stem Cell Corp (ISCO:PINX): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Indus ... Read More
-
Cryo-Cell International Inc (CCEL:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Cryo-Cell International Inc (CCEL:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Cryo-Cell International Inc (CCEL:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. ... Read More
-
Biogen Inc (BIIB:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Biogen Inc (BIIB:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Biogen Inc (BIIB:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new rep ... Read More
-
Agenus Inc (AGEN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Agenus Inc (AGEN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Agenus Inc (AGEN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new rep ... Read More
-
Repligen Corporation (RGEN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Repligen Corporation (RGEN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Repligen Corporation (RGEN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. ... Read More
-
XOMA Corporation (XOMA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
XOMA Corporation (XOMA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry XOMA Corporation (XOMA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This un ... Read More
-
Lineage Cell Therapeutics Inc (LCTX:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Lineage Cell Therapeutics Inc (LCTX:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Lineage Cell Therapeutics Inc (LCTX:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Indus ... Read More
-
Miromatrix Medical Inc (MIRO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Miromatrix Medical Inc (MIRO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Miromatrix Medical Inc (MIRO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findi ... Read More
-
Sorrento Therapeutics Inc (SRNE:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Sorrento Therapeutics Inc (SRNE:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Sorrento Therapeutics Inc (SRNE:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key ... Read More
-
Molecular Templates (MTEM:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Molecular Templates (MTEM:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Molecular Templates (MTEM:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. T ... Read More
-
Acorda Therapeutics Inc (ACOR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Acorda Therapeutics Inc (ACOR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Acorda Therapeutics Inc (ACOR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Fin ... Read More
-
Ambrx Biopharma Inc (AMAM:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Ambrx Biopharma Inc (AMAM:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Ambrx Biopharma Inc (AMAM:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. T ... Read More
Research Assistance
